排序方式：
1.Transarterial chemoembolization with or without multikinase inhibitors for patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysis of randomized controlled trials.
Dong, H, Ge, DF, Qu,
More...
Dong, H, Ge, DF, Qu, B, Zhu, P, Wu, QB, Wang, TY, Wang, J, Li, Z
Less
FRONTIERS IN ONCOLOGY[2234-943X],
Published 2023,
Volume 13,
收錄情况：
WOS
SCOPUS
WOS核心合集引用: 0
2022影響因子:
4.7
2.The key role of sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance
Li, RZ, Wang, XR, Wa
More...
Li, RZ, Wang, XR, Wang, J, Xie, C, Wang, XX, Pan, HD, Meng, WY, Liang, TL, Li, JX, Yan, PY, Wu, QB, Liu, L, Yao, XJ, Leung, ELH
Less
Frontiers in Oncology[2234-943X],
Published 2022,
Volume 12,
收錄情况：
WOS
SCOPUS
WOS核心合集引用: 21
2022影響因子:
4.7
发表年影響因子:
4.7
3.Meta-Analysis of Astragalus-Containing Traditional Chinese Medicine Combined With Chemotherapy for Colorectal Cancer: Efficacy and Safety to Tumor Response
Lin, S, An, XX, Guo,
More...
Lin, S, An, XX, Guo, Y, Gu, JZ, Xie, T, Wu, QB, Sui, XB
Less
FRONTIERS IN ONCOLOGY[2234-943X],
Published 2019,
Volume 9,
Issue AUG,
收錄情况：
WOS
SCOPUS
WOS核心合集引用: 37
2022影響因子:
4.7
发表年影響因子:
4.848
